Home > Resources > Company Profiles > Johnson & Johnson

Johnson & Johnson (JNJ)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Email Confirmation

William C. Weldon , CEO/Chairman of the Board/Director

www.jnj.com

Industry: Healthcare

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

A holding company, which is engaged in research and development, manufacture and sale of products in the health care field. It focuses on products related to human health and well-being.

News Feeds

Final Glance: Pharmaceuticals companies AP
Dec 04 2008
Midday Glance: Pharmaceuticals companies AP
Dec 04 2008
Early Glance: Pharmaceuticals companies AP
Dec 04 2008
Advanced Medical Optics jumps in Tuesday trading AP
Dec 02 2008
J&J to buy breast implant maker Mentor for $1.07B AP
Dec 01 2008
FDA rejects Johnson & Johnson infection treatment AP
Nov 26 2008
Johnson & Johnson paying $438 million for Omrix AP
Nov 24 2008
Medtronic 2Q profit sinks on hefty legal charge AP
Nov 18 2008
IOC still hopeful of $1 billion sponsorship target AP
Nov 18 2008
Ouch: Johnson & Johnson out as Olympic sponsor AP
Nov 18 2008

Portfolio Blogs

First Bytes: AOL, Logitech, Sony, HealthMedia, Yahoo, Google
Oct 29 2008
What Just Happened?
Oct 09 2008
Citi Trading Below Book
Mar 05 2008

The Last AAAngels Standing
Aug 16 2007
The Travails of Johnson & Johnson
Aug 14 2007

Press Releases

Novel Anticoagulants Will Garner More Than Three-Quarters of the Atrial Fibrillation Drug Market in 2017 Dec-04-2008, 08:00AM EST
Catalyst Biosciences Raises $40 Million in Series C Financing Dec-03-2008, 08:30AM EST
Cubist Pharmaceuticals Names Santosh J. Vetticaden as Senior Vice President, Clinical Development and Chief Medical Officer Dec-02-2008, 08:41AM EST
New York Business Group on Health Honors Top Leaders from CIGNA and Johnson & Johnson Dec-01-2008, 03:10PM EST
Johnson & Johnson Announces Definitive Agreement to Acquire Mentor Corporation Dec-01-2008, 08:00AM EST

News From Around the Web

News

Early Glance: Medical Devices companies (Boston Globe)

Dec 04 2008
Final Glance: Medical Devices companies (Businessweek)

Dec 04 2008
Final Glance: Pharmaceuticals companies (Businessweek)

Dec 04 2008
Drug Deals Require Cash (Motley Fool)

Dec 04 2008
Pharmaceuticals companies shares down at noon (Canadian Business Online)

Dec 04 2008
Pharmaceuticals companies shares down at 10 a.m. (Canadian Business Online)

Dec 04 2008
How to Ruin a Perfectly Good Online Ad Campaign, Part 1 (E-Commerce Times)

Dec 04 2008
Continue reading " Bridging disparities" » (MLive.com)

Dec 03 2008

Blogs

Bet on T&A with J&J (JNJ) (Blogging Stocks)

Dec 01 2008
Predictions: 9 For '09 In Pharma (CNBC: Pharmas Market with Mike Huckman)

Dec 01 2008
Johnson & Johnson (JNJ) buying Mentor (MNT) a good sign (Blogging Stocks)

Dec 01 2008
Options Update: Johnson & Johnson and Mentor volatility up into JNJ's buyout (Blogging Stocks)

Dec 01 2008

Employees

Number of Employees: 119,200

Revenue per Employee: $499,959

Top Executives

Stephen J. Cosgrove, Controller/Chief Accounting Officer

Kaye I. Foster-Cheek, Divisional Vice President

Russell C. Deyo, Vice President/General Counsel

Dominic J. Caruso, Divisional Vice President/CFO

Nicholas J. Valeriani, Vice President, Divisional

Board of Directors

Dr. Susan L. Lindquist, Ph.D., Director

Arnold G. Langbo, Director

Dr.Michael M. E. Johns, M.D., Director

Colleen A. Goggins, Chairman of the Board, Divisional

Leo F. Mullin, Director

Dr. David Satcher, M.D., Ph.D., Director

Donald M. Casey, Jr., Chairman of the Board, Divisional

James G. Cullen, Director

Dr.Mary Sue Coleman, Director

Sherilyn S. McCoy, Chairman of the Board, Divisional

Charles Prince, Director

Christine A. Poon, Director/Vice Chairman/Chairman of the Board, Divisional

William D. Perez, Director

Financials

Quarterly

Annual

Income Statement	10/2008	07/2008	05/2008	01/2008
Sales	4.77 Bil.	4.75 Bil.	3.95 Bil.	4.73 Bil.
Gross Operating Profit	11.15 Bil.	11.7 Bil.	12.25 Bil.	11.22 Bil.
Operating Income before D & A (EBITDA)	4.09 Bil.	4.3 Bil.	5.41 Bil.	3.17 Bil.
Total Income Before Interest Expenses (EBIT)	4.29 Bil.	4.12 Bil.	4.84 Bil.	2.33 Bil.
Total Net Income	3.31 Bil.	3.33 Bil.	3.6 Bil.	2.37 Bil.
Basic EPS, Total	1.17	1.17	1.27	0.82
Diluted EPS, Total	1.17	1.17	1.26	0.82

BALANCE STATEMENT	10/2008	07/2008	05/2008	01/2008
Cash and Equivalents	NA	NA	10.54 Bil.	NA
Total Assets	NA	NA	33.82 Bil.	NA
Total Liabilities	NA	NA	22.07 Bil.	NA
Total Capitalization	NA	NA	52.79 Bil.	NA

Cash Flow	10/2008	07/2008	05/2008	01/2008
Net Cash From Continuing Operations	NA	NA	3.24 Bil.	NA
Net Cash From Investing Activities	NA	NA	452 Mil.	NA
Net Cash From Financing Activities	NA	NA	-1.11 Bil.	NA
Net Change in Cash & Cash Equivalents	NA	NA	2.77 Bil.	NA

Income Statement	2008	2007	2006	2005
Sales	17.75 Bil.	12.88 Bil.	11.86 Bil.	11.3 Bil.
Gross Operating Profit	43.34 Bil.	40.44 Bil.	38.65 Bil.	36.05 Bil.
Operating Income before D & A (EBITDA)	15.21 Bil.	15.89 Bil.	15.46 Bil.	14.99 Bil.
Total Income Before Interest Expenses (EBIT)	13.28 Bil.	14.65 Bil.	13.71 Bil.	13.02 Bil.
Total Net Income	10.58 Bil.	11.05 Bil.	10.41 Bil.	8.51 Bil.
Basic EPS, Total	3.63	3.76	3.5	2.87
Diluted EPS, Total	3.63	3.73	3.46	2.84

BALANCE STATEMENT	2008	2007	2006	2005
Cash and Equivalents	NA	4.08 Bil.	16.06 Bil.	9.2 Bil.
Total Assets	NA	22.98 Bil.	31.39 Bil.	27.32 Bil.
Total Liabilities	NA	19.16 Bil.	12.64 Bil.	13.93 Bil.
Total Capitalization	NA	41.33 Bil.	39.89 Bil.	34.38 Bil.

Cash Flow	2008	2007	2006	2005
Net Cash From Continuing Operations	NA	14.25 Bil.	11.88 Bil.	11.13 Bil.
Net Cash From Investing Activities	NA	-20.29 Bil.	-279 Mil.	-2.35 Bil.
Net Cash From Financing Activities	NA	-6.11 Bil.	-4.52 Bil.	-5.15 Bil.
Net Change in Cash & Cash Equivalents	NA	-11.97 Bil.	6.85 Bil.	3.83 Bil.

Johnson & Johnson (JNJ)

Company Information

Overview

Employees

Top Executives

Board of Directors

Financials

Company Profile Change Request